Nothing Special   »   [go: up one dir, main page]

DK1227814T3 - Hormonal sammensætning baseret på nomegestrolacetat og et östrogen samt anvendelse heraf - Google Patents

Hormonal sammensætning baseret på nomegestrolacetat og et östrogen samt anvendelse heraf

Info

Publication number
DK1227814T3
DK1227814T3 DK00971476T DK00971476T DK1227814T3 DK 1227814 T3 DK1227814 T3 DK 1227814T3 DK 00971476 T DK00971476 T DK 00971476T DK 00971476 T DK00971476 T DK 00971476T DK 1227814 T3 DK1227814 T3 DK 1227814T3
Authority
DK
Denmark
Prior art keywords
estrogen
well
composition based
nomegestrol acetate
hormonal composition
Prior art date
Application number
DK00971476T
Other languages
English (en)
Inventor
Jacques Le Clos De Cimie Paris
Jean-Louis Thomas
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Application granted granted Critical
Publication of DK1227814T3 publication Critical patent/DK1227814T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DK00971476T 1999-10-25 2000-10-24 Hormonal sammensætning baseret på nomegestrolacetat og et östrogen samt anvendelse heraf DK1227814T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/FR1999/002588 WO2001030356A1 (fr) 1999-10-25 1999-10-25 Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
PCT/FR2000/002939 WO2001030357A1 (fr) 1999-10-25 2000-10-24 Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation

Publications (1)

Publication Number Publication Date
DK1227814T3 true DK1227814T3 (da) 2005-04-11

Family

ID=9542727

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00971476T DK1227814T3 (da) 1999-10-25 2000-10-24 Hormonal sammensætning baseret på nomegestrolacetat og et östrogen samt anvendelse heraf

Country Status (27)

Country Link
US (2) US8168619B1 (da)
EP (1) EP1227814B1 (da)
JP (1) JP5036943B2 (da)
KR (1) KR100623788B1 (da)
CN (1) CN100553637C (da)
AP (1) AP1625A (da)
AT (1) ATE286400T1 (da)
AU (1) AU777704B2 (da)
BR (1) BRPI0014979B8 (da)
CA (1) CA2389025C (da)
CZ (1) CZ303248B6 (da)
DE (1) DE60017281T2 (da)
DK (1) DK1227814T3 (da)
ES (1) ES2235967T3 (da)
HK (1) HK1050472B (da)
HU (1) HU229382B1 (da)
IL (2) IL148953A0 (da)
MX (1) MXPA02004084A (da)
NO (1) NO327973B1 (da)
NZ (1) NZ518145A (da)
OA (1) OA12072A (da)
PL (1) PL199848B1 (da)
PT (1) PT1227814E (da)
RU (1) RU2261106C2 (da)
SI (1) SI1227814T1 (da)
WO (2) WO2001030356A1 (da)
ZA (1) ZA200203398B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
DE60217324T2 (de) 2001-05-18 2007-04-26 Pantarhei Bioscience B.V. Pharmazeutische zusammensetzung für die hormonersatztherapie
EP1390042B1 (en) 2001-05-23 2007-11-28 Pantarhei Bioscience B.V. Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
WO2002094278A1 (en) 2001-05-23 2002-11-28 Pantarhei Bioscience B.V. Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
PT1446128E (pt) 2001-11-15 2007-03-30 Pantarhei Bioscience Bv Utilização de compostos estrogénicos combinados com compostos progestagénicos na terapia hormonal de substituição
CA2489270C (en) 2002-06-11 2012-08-07 Pantarhei Bioscience B.V. A method of treating human skin and a skin care composition for use in such a method
CA2489271C (en) 2002-06-11 2011-12-06 Pantarhei Bioscience B.V. Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
MXPA04012421A (es) * 2002-06-25 2005-04-19 Wyeth Corp Uso de derivados de ciclotiocarbamato en tratamiento de condiciones relacionadas con la hormona.
CA2492287C (en) 2002-07-12 2011-12-13 Pantarhei Bioscience B.V. Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
AU2003274823A1 (en) 2002-10-23 2004-05-13 Pantarhei Bioscience B.V. Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy
EP2114412B1 (en) 2007-01-08 2010-07-14 Pantarhei Bioscience B.V. Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method
CN107007611B (zh) * 2017-06-02 2020-04-14 上海市计划生育科学研究所 醋酸诺美孕酮在制备治疗子宫内膜癌的药物中的应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
JPS61243059A (ja) 1985-04-19 1986-10-29 Konishi Kagaku Kogyo Kk 高純度４，４′−ジヒドロキシジフエニルスルホンの製造法
DE3603644A1 (de) 1986-02-06 1987-08-13 Metabowerke Kg Spannfutter zum einspannen von bohrern oder schlagbohrern
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
ZA87332B (en) 1986-02-27 1987-08-26 Warner Lambert Co Compositions containing fixed combinations
US5108995A (en) 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5276022A (en) 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5256421A (en) 1987-09-24 1993-10-26 Jencap Research Ltd. Hormone preparation and method
DE3888269T2 (de) 1987-09-24 1994-07-07 Jencap Research Ltd Hormon-Zusammensetzung und -Anwendung.
CA1332227C (en) 1987-09-24 1994-10-04 Robert F. Casper Oral contraceptive formulation
HUT52382A (en) 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
IE71203B1 (en) 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
FR2695826B1 (fr) 1992-09-21 1995-01-06 Theramex Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
US5554601A (en) 1993-11-05 1996-09-10 University Of Florida Methods for neuroprotection
US5552394A (en) 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
US6613757B1 (en) 1994-09-22 2003-09-02 Board Of Regents, The University Of Texas System Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
SE9403389D0 (sv) 1994-10-06 1994-10-06 Astra Ab Pharmaceutical composition containing derivattves of sex hormones
FR2737411B1 (fr) 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
JPH11511128A (ja) 1995-08-01 1999-09-28 ノバルティス・アクチエンゲゼルシャフト リポソームオリゴヌクレオチド組成物
US5888543A (en) 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
DE19739916C2 (de) 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
PT1443966E (pt) * 2001-11-15 2007-06-21 Pantarhei Bioscience Bv Método para a prevenção ou tratamento das doenças ginecológicas benignas
AR065816A1 (es) 2007-03-26 2009-07-01 Theramex Regimen anticonceptivo oral

Also Published As

Publication number Publication date
OA12072A (fr) 2006-05-04
IL148953A (en) 2007-06-03
HUP0203721A2 (hu) 2003-03-28
NO20021949D0 (no) 2002-04-25
PL356847A1 (en) 2004-07-12
CN1382053A (zh) 2002-11-27
EP1227814A1 (fr) 2002-08-07
US20130172300A1 (en) 2013-07-04
BRPI0014979B1 (pt) 2016-08-02
KR100623788B1 (ko) 2006-09-18
CZ303248B6 (cs) 2012-06-20
NZ518145A (en) 2005-01-28
ATE286400T1 (de) 2005-01-15
HUP0203721A3 (en) 2003-07-28
CZ20021427A3 (cs) 2002-08-14
ES2235967T3 (es) 2005-07-16
HU229382B1 (hu) 2013-11-28
DE60017281D1 (de) 2005-02-10
NO20021949L (no) 2002-04-25
AU777704B2 (en) 2004-10-28
JP2003515531A (ja) 2003-05-07
ZA200203398B (en) 2003-12-03
SI1227814T1 (en) 2005-06-30
HK1050472A1 (en) 2003-06-27
CN100553637C (zh) 2009-10-28
EP1227814B1 (fr) 2005-01-05
HK1050472B (zh) 2005-07-08
PT1227814E (pt) 2005-05-31
CA2389025A1 (fr) 2001-05-03
JP5036943B2 (ja) 2012-09-26
WO2001030357A1 (fr) 2001-05-03
US9084796B2 (en) 2015-07-21
PL199848B1 (pl) 2008-11-28
AU1032601A (en) 2001-05-08
MXPA02004084A (es) 2003-08-20
US8168619B1 (en) 2012-05-01
NO327973B1 (no) 2009-11-02
WO2001030356A1 (fr) 2001-05-03
CA2389025C (fr) 2009-12-08
AP2002002475A0 (en) 2002-06-30
KR20020057979A (ko) 2002-07-12
BRPI0014979B8 (pt) 2021-05-25
IL148953A0 (en) 2002-11-10
DE60017281T2 (de) 2005-12-08
AP1625A (en) 2006-07-04
RU2002113652A (ru) 2004-03-27
RU2261106C2 (ru) 2005-09-27
BR0014979A (pt) 2002-11-26

Similar Documents

Publication Publication Date Title
DK1227814T3 (da) Hormonal sammensætning baseret på nomegestrolacetat og et östrogen samt anvendelse heraf
EA200201000A1 (ru) Гормон-заместительная терапия
AR073972A2 (es) Composiciones farmaceuticas para el tratamiento de carencias estrogenicas en la menopausia y para la prevencion de la osteoporosis en mujeres menopausicas
NO975586D0 (no) Transdermal innretning og fremgangsmåte for administrering av 17-deacetyl norgestimat alene eller i kombinasjon med et östrogen
AR024566A1 (es) Administracion de esteroides androgenicos no orales a mujeres
SE9704870D0 (sv) New pharmaceutical formulation I
CR7420A (es) Composiciones farmaceuticas que comprenden uno o varios esteroides, uno o varios componentes de tetrahiidrofolatos y vitamina b12
KR960700727A (ko) 호르몬 대체 치료(hormone replacement therapy)
ATE215081T1 (de) Gonadotropin releasing hormon- antagonisten
NO993979L (no) FremgangsmÕte for Õ forhindre og forsinke starten pÕ Alzheimer's sykdom og sammensetning derfor
RS50972B (sr) Farmaceutski sastav koji sadrži gestagene i/ili estrogene i 5-metil-(6s)-tetrahidrofolate
BG105856A (en) Use of hydroxymatairesinol in cancer prevention
BR9509155A (pt) Apilcação de inibidores de aromatase para preparação de um medicamento para tratamento de uma deficiência relativa de andrôgeno no homem
MX2007013137A (es) Regimen anticonceptivo con dosificacion de estrogeno ampliada.
EA200301022A1 (ru) Гормональная заместительная терапия
NZ522242A (en) Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
TW200626161A (en) Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
ATE198707T1 (de) Prostaglandinanaloga zur oralen oder vaginalen verabreichung in der routinebehandlung des dritten stadiums der geburtswehen
CO4960657A1 (es) Composicion farmaceutica
AR049196A1 (es) Anticonceptivo hormonal conteniendo una combinacion de etinilestradiol y acetato de clormadinona
AU6567800A (en) Substances and agents for positively influencing collagen
AR039477A1 (es) Terapia de reemplazo hormonal
DE59404903D1 (de) Oral estrogen wirksame ester des 14 alpha,15 alpha-methylen-estradiols
TR200102262T2 (tr) Koroner müdahale ile ilgili kardiovasküler olayların önlenmesi veya azaltılması için yöntem.
MD1715F1 (en) Method of prophylaxis and treatment of the precocious hypogalactia